The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

…, NE Lane, CV Oddis, F Wolfe… - … : Official Journal of …, 2008 - Wiley Online Library
Objective Osteoarthritis (OA) of the knee causes significant morbidity and current medical
treatment is limited to symptom relief, while therapies able to slow structural damage remain …

Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from …

…, CG Jackson, NE Lane, CV Oddis, F Wolfe… - Annals of the …, 2010 - ard.bmj.com
Background Knee osteoarthritis (OA) is a major cause of pain and functional limitation in
older adults, yet longer-term studies of medical treatment of OA are limited. Objective To …

Minimal disease activity for rheumatoid arthritis: a preliminary definition.

…, PLCM Van Riel, F Wolfe… - The Journal of …, 2005 - jrheum.org
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization
and interpretation of clinical trial reports. With recent advances in therapy, the proportion …

A comparison of patient characteristics and outcomes in selected European and US rheumatoid arthritis registries

…, N Shadick, DH Solomon, ME Weinblatt, F Wolfe… - Seminars in arthritis and …, 2010 - Elsevier
PURPOSE: Randomized controlled trials (RCTs) have demonstrated the efficacy of biologic
agents in the treatment of rheumatic diseases. However, results from RCTs may not be …

Biologic drugs for rheumatoid arthritis in the Medicare program: a cost‐effectiveness analysis

…, K Michaud, RM Nixon, F Wolfe - Arthritis & …, 2008 - Wiley Online Library
Objective Since the introduction of the Medicare Prescription Drug Improvement and
Modernization Act and its associated demonstration project, coverage of selected biologic drugs …

[PDF][PDF] Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta …

W Häuser, P Sarzi-Puttini, TR Tölle, F Wolfe - Clin Exp Rheumatol, 2012 - researchgate.net
Objective. The superiority of true drug treatment over placebo in reducing symptoms of
fibromyalgia syndrome (FMS) is small and bought by relevant rates of drop-outs due to adverse …

Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up …

J Langhorst, A Hofstetter, F Wolfe… - Inflammatory bowel …, 2013 - academic.oup.com
Background Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease.
Psychological factors such as depression and stress are under debate to contribute to the risk of …

The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis

M Hernández Alava, A Wailoo, F Wolfe… - Rheumatology, 2013 - academic.oup.com
Objective. This study aims to provide robust estimates of EQ-5D as a function of the HAQ and
pain in patients with RA. Method. Repeated observations were made of patients diagnosed …

Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis.

…, GR Norton, AJ Woodiwiss, BI Joffe, F Wolfe - The Journal of …, 2007 - jrheum.org
OBJECTIVE: To determine whether nontraditional risk factors increase the accuracy of
predicting the presence of carotid artery plaque based on traditional cardiovascular risk factors …

A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes

M Hernández Alava, A Wailoo, F Wolfe… - Medical Decision …, 2014 - journals.sagepub.com
Background: Analysts frequently estimate health state utility values from other outcomes.
Utility values like EQ-5D have characteristics that make standard statistical methods …